Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Policy
At the request of FDA's chief scientist, Frank M. Torti, the agency's Science Board has established a new subcommittee to review the safety of the plastics chemical bisphenol A (BPA), a known endocrine disrupter. In April, because of an ongoing congressional investigation and a media firestorm focusing on the use of BPA in consumer products such as baby bottles and infant formula containers, FDA Commissioner Andrew C. von Eschenbach formed an agency-wide task force to review the safety of BPA in all FDA-regulated products. The new Science Board subcommittee will review a report this fall from that task force and hold a public meeting on the topic later this year, FDA Associate Commissioner for Science Norris E. Alderson said at a House Energy & Commerce subcommittee hearing on June 10. Alderson chairs FDA's BPA Task Force.
This article has been sent to the following recipient: